Activity identification of anti-caspase-3 mRNA hammerhead ribozyme in both cell-free condition and BRL-3A cells

Chinese Medical Journal

Volumn 114, Issue 6, 2001, Pages 606-611

  Xu, Renhuan H ^a   Liu, Jing ^b   Zhou, Xiaqiu Q ^a   Xie, Qing ^a   Jin, Youxin X ^b   Yu, Hong ^a   Liao, Dan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Activity identification; Apoptosis inhibitor; BRL 3A; Caspase 3; Ribozyme

Indexed keywords

CASP3 PROTEIN, RAT; CASPASE; CASPASE 3; MESSENGER RNA; RIBOZYME; RNA;

ANIMAL; ARTICLE; CELL FREE SYSTEM; CELL LINE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; KINETICS; METABOLISM; PLASMID; RAT; TEMPERATURE; TIME;

ANIMALS; CASPASE 3; CASPASES; CELL LINE; CELL-FREE SYSTEM; KINETICS; PLASMIDS; RATS; RNA; RNA, CATALYTIC; RNA, MESSENGER; TEMPERATURE; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0035382934     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Leist M, Gantner F, Bohlinger I, et al. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995;146:1220-1234.
2. Kuo PC, Alfrey EJ, Krieger NR, et al. Differential localization of allograft nitric oxide synthesis : comparison of liver and heart transplantation in the rat model. Immunology 1996;87:647-653.
3. Bohlinger I, Leist M, Barsig J, et al. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology 1995; 22: 1829-1837.
4. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/ CED-3 protease nomenclature. Cell 1996;87:171-174.
5. Enari M, Talanian RV, Wong WW, et al. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996;380:723-726.
6. Rodriguez IK, Matsuura CS, Nafata, et al. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 1996; 184: 2067-2072.
7. Inayat-Hussain, Couet SHC, Cohen GM, et al. Processing/ activation of CPP32-like proteases is involved in transforming growth factor β-induced apoptosis in rat hepatocytes. Hepatology 1997;25:1516-1523.
8. Jaeschke H, Fisher MA, Lawson JA, et al. Activation of caspase-3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutuphil-mediated necrosis in a murine endotoxin shock model. J Immunol 1998; 160:3480-3486.
9. Woo M, Hakem A, Elia AJ, et al. In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes. J Immunol 1999; 163:4990-4916.
10. Ekert PG, Silke J, Vaux DL. Caspase-3/inhibitors. Cell Death Dif 1999;6:1081-1086.
11. Kijima H, Ishida H, Ohkawa T, et al. Therapeutic application of ribozymes. Pharmacol Ther 1995;68:247-264.
12. DeZhong L, YouXin J, Hua H, et al. Preparation and identification of activity of anti-HPV-6b/11E1 universal ribozyme-Rz1198 in vitro. Asian J Androl 1999;1:195-201.
13. Uhlenbeck OC. A small catalytic oligoribonucleotide. Natute 1987;328:569-600.
14. Bettrand E, Pictet R, Grange T. Can heamerhead ribozymes be efficient tools inactivate gene function? Nucleic Acids Res 1994; 22:293-300.
15. Ferbeyre G, Bratty J, Chen H, et al. A heamerhead ribozyme inhibits ADE1 gene expression in yeast. Gene 1995;155:45-50.
16. Cantor GH, Mcelwain TF, Birkebak TA, et al. Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression. Proc Natl Acad Sci U S A 1993;90:10932-10936.